Lykos Therapeutics’ Post

Today, we announce new initiatives and measures for additional oversight for midomafetamine capsules in combination with psychological intervention (“midomafetamine-assisted therapy”) for the treatment of #PTSD in adults, if approved by the FDA: - Establishing an independent advisory board   - Working with top behavioral health facilities   - Collaborating with others on training    Learn more about our dedication to patient safety here: https://lnkd.in/ePzQa66U

  • text
Wendy Bond, M.D.

Medical Director at Alzheimer’s Diagnostic Centers | Expert in Alzheimer’s Diagnosis & FDA-Approved Treatments | Patient Advocate Redefining Alzheimer’s care in Southwest Florida

8mo

Yes!!

Like
Reply
Jeremy M.

Jeremy is a Purpose-Driven Sales Expert | With the adversity came a shift in values equating to a crossroads between purposeful projects and profit Being true to self is higher than the $

8mo

Fantastic update!

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics